Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 Next >
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
Tags Novo Nordisk A/S Breaking news Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
Tags Business Eli Lilly and Co Health & Science
From CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
Tags Business News Biotechnology Novo Nordisk A/S
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Pharmaceuticals Companies Health care industry
From CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
Tags Business Eli Lilly and Co Health & Science
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
Tags Health care industry Technology Dexcom Inc
From CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
Tags Hess Corp Markets Consumer Price Index
From CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
Tags Exxon Mobil Corp Advanced Micro Devices Inc Intel Corp
From CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
Tags Health care industry Investing Health & Science
From CNBC.com News
Sanofi to offer insulin product for $35 to all Americans through GoodRx
Tags US: News Biotechnology Business News
From CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Tags Finance Breaking News: Investing Weight loss surgery
From CNBC.com News
Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
Tags Pharmaceuticals Companies Health care industry
From CNBC.com News
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Tickers BIRK EVS MSFT NVO
Tags Tempest Therapeutics Equities MSFT
From Benzinga
How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains
Tags Walmart Inc Abbott Laboratories stocks
From CNBC.com News
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
Tags Take/Two Interactive Software Inc stocks Economy
From CNBC.com News
Stocks making the biggest moves premarket: Plug Power, Exxon Mobil, Pioneer, Novo Nordisk and more
Tags Business Humana Inc Pioneer Natural Resources Co
From CNBC.com News
LVMH shares fall to 2023 low as growth slows, pulling luxury sector down
Tags LVMH Moet Hennessy Louis Vuitton SE Earnings Novo Nordisk A/S
From CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
Tickers CEO
Tags Biotech and Pharmaceuticals Weight management Novo Nordisk A/S
From CNBC.com News
Here are 20 stocks I'm watching Tuesday, including Lilly, AMD and Goldman Sachs
Tags Walgreens Boots Alliance Inc Breaking News: Markets Robinhood Markets Inc
From CNBC.com News
Weight loss drugs may be linked to stomach paralysis, other rare but severe issues, study says
Tags Biotech and Pharmaceuticals Breaking news Science
From CNBC.com News
Here are 18 stocks I am watching in the market, including Clorox, Rivian and Airbnb
Tags Clorox Co Marathon Petroleum Corp Investing
From CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
Tags Biotech and Pharmaceuticals Breaking news Abbvie Inc
From CNBC.com News
Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom
Tags General Mills Inc Food and Beverage Health & Science
From CNBC.com News
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
Tags US: News Biotechnology Structure Therapeutics Inc
From CNBC.com News
Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million
Tags Biotech and Pharmaceuticals US: News Breaking news
From CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
Tags US: News Business News Biotechnology
From CNBC.com News
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
Tags Business News Biotechnology US: News
From CNBC.com News
Here's why Jim Cramer likes J.M. Smucker's plan to buy the maker of Twinkies
Tags Mergers Markets Investing
From CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
Tags Pharmaceuticals Companies Health care industry
From CNBC.com News
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
Tags CNBC Global CFO Council Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.